The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages
Open accessAbstract
The therapeutic use of bacteriophages has seen a renewal of interest blossom in the last few years. This reversion is due to increased difficulties in the treatment of antibiotic-resistant strains of bacteria. Bacterial resistance to antibiotics, a serious problem in contemporary medicine, does not implicate resistance to phage lysis mechanisms. Lytic bacteriophages are able to kill antibiotic-resistant bacteria at the end of the phage infection cycle. Thus, the development of phage therapy is potentially a way to improve the treatment of bacterial infections. However, there are antibacterial phage therapy difficulties specified by broadening the knowledge of the phage nature and influence on the host. It has been shown during experiments that both innate and adaptive immunity are involved in the clearance of phages from the body. Immunological reactions against phages are related to the route of administration and may vary depending on the type of bacterial viruses. For that reason, it is very important to test the immunological response of every single phage, particularly if intravenous therapy is being considered. The lack of these data in previous years was one of the reasons for phage therapy abandonment despite its century-long study. Promising results of recent research led us to look forward to a phage therapy that can be applied on a larger scale and subsequently put it into practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Holins: The Protein Clocks of Bacteriophage Infections
Wang, I.-N., Smith, D. L., & Young, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.799 · Cited by 806
Bacteriophage Endolysins as Novel Antimicrobials
Schmelcher, M., Donovan, D. M., & Loessner, M. J. (2012) · Future Microbiology · doi:10.2217/fmb.12.97 · Cited by 785
Bacteriophage endolysins — current state of research and applications
Loessner, M. J. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.002 · Cited by 537
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Going viral: next-generation sequencing applied to phage populations in the human gut
Reyes, A., Semenkovich, N. P., Whiteson, K., Rohwer, F., & Gordon, J. I. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2853 · Cited by 441
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Nelson, D. C., Schmelcher, M., Rodriguez-Rubio, L., Klumpp, J., Pritchard, D. G., Dong, S., & Donovan, D. M. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00007-4 · Cited by 372
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Bacteriophage Endolysins as a Novel Class of Antibacterial Agents
Borysowski, J., Weber-Dąbrowska, B., & Górski, A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100402 · Cited by 338
The factors affecting effectiveness of treatment in phages therapy
Ly-Chatain, M. H. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00051 · Cited by 331
Barrow, P., Lovell, M., & Berchieri, A. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.294-298.1998 · Cited by 293
The strange history of phage therapy
Summers, W. C. (2012) · Bacteriophage · doi:10.4161/bact.20757 · Cited by 284
Phage as a Modulator of Immune Responses
Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 266
Viertel, T. M., Ritter, K., & Horz, H.-P. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku173 · Cited by 243
Phage therapy gets revitalized
Reardon, S. (2014) · Nature · doi:10.1038/510015a · Cited by 241
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh
Sarker, S. A., McCallin, S., Barretto, C., Berger, B., Pittet, A.-C., Sultana, S., Krause, L., Huq, S., Bibiloni, R., Bruttin, A., et al. (2012) · Virology · doi:10.1016/j.virol.2012.09.002 · Cited by 240
Bacteriophage penetration in vertebrates
Dabrowska, K., Switala-Jelen, K., Opolski, A., Weber-Dabrowska, B., & Gorski, A. (2005) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02422.x · Cited by 240
Bacteriophages and Phage-Derived Proteins – Application Approaches
Drulis-Kawa, Z., Majkowska-Skrobek, G., & Maciejewska, B. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209152851 · Cited by 234
Górski, A., Ważna, E., DÄ browska, B.-W., DÄ browska, K., ÅwitaÅa-JeleÅ, K., & MiÄdzybrodzki, R. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00044.x · Cited by 227
Carvalho, C. M., Gannon, B. W., Halfhide, D. E., Santos, S. B., Hayes, C. M., Roe, J. M., & Azeredo, J. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-232 · Cited by 223
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1127 · Cited by 202
Fate of Bacteriophage Lambda in Non-immune Germ-free Mice
GEIER, M. R., TRIGG, M. E., & MERRIL, C. R. (1973) · Nature · doi:10.1038/246221a0 · Cited by 191
Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage
López, R., & García, E. (2004) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.05.002 · Cited by 187
Bacteriophage Therapy in Humans
Sulakvelidze, A., & Kutter, E. (2004) · Bacteriophages · doi:10.1201/9780203491751.ch14 · Cited by 170
Fc receptor-mediated antiviral antibodies
Forthal, D. N., & Moog, C. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832f0a89 · Cited by 156
Bacteriophage Therapy ofSalmonella enterica:A Fresh Appraisal of Bacteriophage Therapy
Capparelli, R., Nocerino, N., Iannaccone, M., Ercolini, D., Parlato, M., Medaglia, C., & Iannelli, D. (2009) · The Journal of Infectious Diseases · doi:10.1086/648478 · Cited by 120
Molecular Basis for Lytic Bacteriophage Resistance in Enterococci
Duerkop, B. A., Huo, W., Bhardwaj, P., Palmer, K. L., & Hooper, L. V. (2016) · mBio · doi:10.1128/mbio.01304-16 · Cited by 112
Bacteriophage endolysins as a response to emerging foodborne pathogens
Oliveira, H., Azeredo, J., Lavigne, R., & Kluskens, L. (2012) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2012.06.016 · Cited by 94
Effects of bacteriophages on free radical production and phagocytic functions
Przerwa, A., Zimecki, M., Świtała-Jeleń, K., Dąbrowska, K., Krawczyk, E., Łuczak, M., Weber‐Dąbrowska, B., Syper, D., Międzybrodzki, R., & Górski, A. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0011-4 · Cited by 92
Linden, S. B., Zhang, H., Heselpoth, R. D., Shen, Y., Schmelcher, M., Eichenseher, F., & Nelson, D. C. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5930-1 · Cited by 92
Control ofcampylobacterin poultry industry from farm to poultry processing unit: A review
Umaraw, P., Prajapati, A., Verma, A. K., Pathak, V., & Singh, V. P. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.935847 · Cited by 91
Magnone, J., Marek, P. J., Sulakvelidze, A., & SENECAL, A. G. (2013) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-12-517 · Cited by 90
Immunological factors that affect the in vivo fate of T7 phage in the mouse
Srivastava, A., Kaido, T., & Carrier, E. (2003) · Journal of Virological Methods · doi:10.1016/j.jviromet.2003.09.009 · Cited by 72
Phospholipid vesicles encapsulated bacteriophage: A novel approach to enhance phage biodistribution
Singla, S., Harjai, K., Raza, K., Wadhwa, S., Katare, O. P., & Chhibber, S. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.07.002 · Cited by 67
Phage display as a novel promising antivenom therapy: A review
Roncolato, E. C., Campos, L. B., Pessenda, G., Silva, L. C., Furtado, G. P., & Barbosa, J. E. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.11.001 · Cited by 52
Bacteriophage Cocktail for Biocontrol of Salmonella in Dried Pet Food
Heyse, S., Hanna, L. F., Woolston, J., Sulakvelidze, A., & Charbonneau, D. L. (2015) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-14-041 · Cited by 32
Geller, B. L., Kraus, J., Schell, M. D., Hornsby, M. J., Neal, J. J., & Ruch, F. E. (1998) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(98)75648-6 · Cited by 10
Cited by
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus
Guo, Y., Song, G., Sun, M., Wang, J., & Wang, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00107 · Cited by 870
Molecular and Evolutionary Determinants of Bacteriophage Host Range
de Jonge, P. A., Nobrega, F. L., Brouns, S. J. J., & Dutilh, B. E. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.006 · Cited by 475
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Isler, B., Doi, Y., Bonomo, R. A., & Paterson, D. L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01110-18 · Cited by 293
Metadata
- Authors
- Cisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, Z.
- Venue
- Current Microbiology
- Published
- 2016-11-28
- Volume
- 74
- Issue
- 2
- Pages
- 277-283
- ISSN
- 0343-8651 (ISSN-L)
- 1432-0991
- OpenAlex
- W2557612124
- Cited by
- 318
- References
- 42
- FWCI
- 21.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.